Contact

All Stories

  1. Quality of life domains revised by people with multiple sclerosis and healthcare professionals for adaptive measure development

    Article • PLOS One, June 2026, PLOS

    Dr. Alessandra Solari

  2. Correction: Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two‑year Phase IV CLARIFY‑MS Study

    Article • Neurology and Therapy, June 2026, Springer Science + Business Media

    Professor Fredrik Piehl, Dr. Alessandra Solari

  3. Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two-year Phase IV CLARIFY-MS Study

    Article • Neurology and Therapy, March 2026, Springer Science + Business Media

    Professor Fredrik Piehl, Dr. Alessandra Solari

  4. Advance care planning in multiple sclerosis (ConCure-SM): A multicenter single-arm pilot and feasibility study

    Article • PLOS One, October 2025, PLOS

    Dr. Alessandra Solari

  5. Healthcare for adults with long-term neurological conditions: European Academy of Neurology Members Survey

    Article • BMJ Supportive & Palliative Care, June 2025, BMJ

    Dr. Alessandra Solari

  6. Diagnostic delay and misdiagnosis of symptoms reported by patients with multiple sclerosis participating in a research registry

    Article • Multiple Sclerosis Journal - Experimental Translational and Clinical, April 2025, SAGE Publications

    Dr. Alessandra Solari

  7. Correction to: Neurology and physician-assisted suicide: position of the Italian society of neurology

    Article • Neurological Sciences, March 2025, Springer Science + Business Media

    Dr. Alessandra Solari

  8. Neurology and physician-assisted suicide: position of the Italian society of neurology

    Article • Neurological Sciences, February 2025, Springer Science + Business Media

    Dr. Alessandra Solari

  9. Neurology and physician-assisted suicide: glossary of definitions and terminology

    Article • Neurological Sciences, February 2025, Springer Science + Business Media

    Dr. Alessandra Solari

  10. Treatment effect modifiers of immunotherapies for relapsing-remitting multiple sclerosis—A systematic review and meta-analysis

    Article • Multiple Sclerosis Journal - Experimental Translational and Clinical, October 2024, SAGE Publications

    Dr. Alessandra Solari

  11. Education needs in palliative care and advance care planning of Italian residents in neurology: an online survey

    Article • European Journal of Neurology, June 2024, Wiley

    Dr. Alessandra Solari

  12. Improvements in quality of life over 2 years with cladribine tablets in people with relapsing multiple sclerosis: The CLARIFY-MS study

    Article • Multiple Sclerosis Journal, November 2023, SAGE Publications

    Professor Fredrik Piehl, Dr. Alessandra Solari

  13. Applying multidimensional computerized adaptive testing to the MSQOL-54: a simulation study

    Article • Health and Quality of Life Outcomes, June 2023, Springer Science + Business Media

    Dr. Alessandra Solari

  14. Italian cross-cultural adaptation of the Quality of Communication questionnaire and the 4-item advance care planning engagement questionnaire

    Article • PLOS One, March 2023, PLOS

    Dr. Alessandra Solari

  15. Italian cross-cultural adaptation of the patient-reported outcome measure of ataxia

    Article • Neurological Sciences, March 2023, Springer Science + Business Media

    Dr. Alessandra Solari

  16. Patient and carer involvement in the formulation of research questions: findings from the Italian guideline on palliative care in adults with glioma

    Article • Neurological Sciences, February 2023, Springer Science + Business Media

    Dr. Alessandra Solari

  17. Postpartum relapse risk in multiple sclerosis: a systematic review and meta-analysis

    Article • Journal of Neurology Neurosurgery & Psychiatry, February 2023, BMJ

    Dr. Alessandra Solari

  18. Health professional involvement in the formulation of research questions: findings from the Italian guideline on palliative care in adults with glioma

    Article • Neurological Sciences, January 2023, Springer Science + Business Media

    Dr. Alessandra Solari

  19. Diagnosis concealment is prevalent in MS, and associated with diagnosis experience

    Article • Multiple Sclerosis and Related Disorders, December 2022, Elsevier

    Dr. Alessandra Solari

  20. Motherhood choice in multiple sclerosis (MoMS) development and piloting of patient-reported outcome measures

    Article • Multiple Sclerosis and Related Disorders, July 2022, Elsevier

    Dr. Alessandra Solari

  21. A group resilience training program for people with multiple sclerosis: Study protocol of a multi-centre cluster-randomized controlled trial (multi-READY for MS)

    Article • PLOS One, May 2022, PLOS

    Emeritus Professor Kenneth Ian Pakenham, Dr. Alessandra Solari

  22. Cross-Country Adaptation of a Psychological Flexibility Measure: The Comprehensive Assessment of Acceptance and Commitment Therapy Processes

    Article • International Journal of Environmental Research and Public Health, March 2022, MDPI AG

    Emeritus Professor Kenneth Ian Pakenham, Dr. Alessandra Solari

  23. Evaluation of a program for training psychologists in an acceptance and commitment therapy resilience intervention for people with multiple sclerosis: a single-arm longitudinal design with a nested qualitative study

    Article • Disability and Rehabilitation, February 2022, Taylor & Francis

    Emeritus Professor Kenneth Ian Pakenham, Dr. Alessandra Solari

  24. Advance Care Planning in Neurodegenerative Disorders: A Scoping Review

    Article • International Journal of Environmental Research and Public Health, January 2022, MDPI AG

    Dr. Alessandra Solari

  25. Treatment satisfaction, safety, and tolerability of cladribine tablets in patients with highly active relapsing multiple sclerosis: CLARIFY-MS study 6-month interim analysis

    Article • Multiple Sclerosis and Related Disorders, January 2022, Elsevier

    Professor Dawn Langdon, Professor Fredrik Piehl, Dr. Alessandra Solari

  26. Correction to: Diagnosis and treatment of Chiari Malformation and syringomyelia in adults: International Consensus Document

    Article • Neurological Sciences, November 2021, Springer Science + Business Media

    Dr. Alessandra Solari

  27. The development and use of the European academy of neurology guideline on palliative care in advanced progressive multiple sclerosis

    Article • Journal of the Neurological Sciences, October 2021, Elsevier

    Professor Ivan G. Milanov, Dr. Alessandra Solari

  28. Construction of a resource for advance care planning in multiple sclerosis (ConCure-SM): Results of cognitive debriefing with users

    Article • Journal of the Neurological Sciences, October 2021, Elsevier

    Luca Ghirotto, Dr. Alessandra Solari

  29. Involving patients and caregivers in the production of guidelines for palliative care in primary brain tumours: Identification of intervention priorities

    Article • Journal of the Neurological Sciences, October 2021, Elsevier

    Dr. Alessandra Solari

  30. The management of Chiari malformation type 1 and syringomyelia in children: a review of the literature

    Article • Neurological Sciences, September 2021, Springer Science + Business Media

    Dr. Alessandra Solari

  31. Viability of a MSQOL-54 general health-related quality of life score using bifactor model

    Article • Health and Quality of Life Outcomes, September 2021, Springer Science + Business Media

    Dr. Alessandra Solari

  32. Effectiveness of a group resilience intervention for people with multiple sclerosis delivered via frontline services

    Article • Disability and Rehabilitation, August 2021, Taylor & Francis

    Emeritus Professor Kenneth Ian Pakenham, Dr. Alessandra Solari

  33. Study protocol on advance care planning in multiple sclerosis (ConCure-SM): intervention construction and multicentre feasibility trial

    Article • BMJ Open, August 2021, BMJ

    Dr. Alessandra Solari

  34. Diagnosis and treatment of Chiari malformation and syringomyelia in adults: international consensus document

    Article • Neurological Sciences, June 2021, Springer Science + Business Media

    Dr. Alessandra Solari

  35. Diagnosis and treatment of Chiari malformation type 1 in children: the International Consensus Document

    Article • Neurological Sciences, June 2021, Springer Science + Business Media

    Dr. Alessandra Solari

  36. Living with severe multiple sclerosis: Cost-effectiveness of a palliative care intervention and cost of illness study

    Article • Multiple Sclerosis and Related Disorders, April 2021, Elsevier

    Dr. Alessandra Solari

  37. The impact of the COVID-19 pandemic on people with neurological disorders: an urgent need to enhance the health care system’s preparedness

    Article • Neurological Sciences, January 2021, Springer Science + Business Media

    Dr. Alessandra Solari

  38. The Impact of the SARS-CoV-2 Outbreak on the Psychological Flexibility and Behaviour of Cancelling Medical Appointments of Italian Patients with Pre-Existing Medical Condition: The “ImpACT-COVID-19 for Patients” Multi-Centre Observational Study

    Article • International Journal of Environmental Research and Public Health, January 2021, MDPI AG

    Dr. Alessandra Solari

  39. EAN Guideline on Palliative Care of People with Severe, Progressive Multiple Sclerosis

    Article • Journal of Palliative Medicine, November 2020, Mary Ann Liebert Inc

    Dr. Ron Milo, Professor Ivan G. Milanov, Dr. Alessandra Solari

  40. “I Will Respect the Autonomy of My Patient”

    Article • International Journal of MS Care, November 2020, Consortium of Multiple Sclerosis Centers

    Dr. Alessandra Solari

  41. 27th Annual Conference of the International Society for Quality of Life Research

    Article • Quality of Life Research, October 2020, Springer Science + Business Media

    Dr. Alessandra Solari

  42. The impact of the face-to-face consultation on decisional conflict in complex decision-making in multiple sclerosis: A pilot study

    Article • Multiple Sclerosis Journal - Experimental Translational and Clinical, October 2020, SAGE Publications

    Dr. Alessandra Solari

  43. Implementation of a complex intervention to improve care for patients whose situations are clinically uncertain in hospital settings: A multi-method study using normalisation process theory

    Article • PLOS One, September 2020, PLOS

    Dr. Alessandra Solari

  44. Construction of a User-Led Resource for People Transitioning to Secondary Progressive Multiple Sclerosis: Results of an International Nominal Group Study

    Article • Frontiers in Neurology, August 2020, Frontiers

    Dr. Alessandra Solari

  45. Identifying Progression in Multiple Sclerosis: New Perspectives

    Article • Annals of Neurology, July 2020, Wiley

    Dr. Alessandra Solari, Professor Dawn Langdon

  46. Italian consensus and recommendations on diagnosis and treatment of low-grade gliomas. An intersociety (SINch/AINO/SIN) document

    Article • Journal of Neurosurgical Sciences, July 2020, Edizioni Minerva Medica

    Dr. Alessandra Solari

  47. Aggressive multiple sclerosis (1): Towards a definition of the phenotype

    Article • Multiple Sclerosis Journal, June 2020, SAGE Publications

    Dr. Alessandra Solari

  48. Aggressive multiple sclerosis (2): Treatment

    Article • Multiple Sclerosis Journal, June 2020, SAGE Publications

    Dr. Alessandra Solari

  49. Palliative care in multiple sclerosis: European guideline

    Article • Multiple Sclerosis Journal, June 2020, SAGE Publications

    Dr. Alessandra Solari, Professor Ivan G. Milanov

  50. EAN guideline on palliative care of people with severe, progressive multiple sclerosis

    Article • European Journal of Neurology, May 2020, Wiley

    Dr. Alessandra Solari, Dr. Ron Milo, Professor Ivan G. Milanov

  51. A resilience group training program for people with multiple sclerosis: Results of a pilot single-blind randomized controlled trial and nested qualitative study

    Article • PLOS One, April 2020, PLOS

    Dr. Alessandra Solari, Emeritus Professor Kenneth Ian Pakenham

  52. Conversion to secondary progressive multiple sclerosis: Multistakeholder experiences and needs in Italy

    Article • PLOS One, February 2020, PLOS

    Dr. Alessandra Solari

  53. Italian consensus on treatment of spasticity in multiple sclerosis

    Article • European Journal of Neurology, December 2019, Wiley

    Dr. Alessandra Solari

  54. 029 Importance of face-to-face consultation in complex decision-making

    Article • Journal of Neurology Neurosurgery & Psychiatry, November 2019, BMJ

    Dr. Alessandra Solari

  55. Assessing measurement invariance of MSQOL-54 across Italian and English versions

    Article • Quality of Life Research, November 2019, Springer Science + Business Media

    Dr. Alessandra Solari

  56. A Framework for Estimating the Burden of Chronic Diseases: Design and Application in the Context of Multiple Sclerosis

    Article • Frontiers in Neurology, September 2019, Frontiers

    Dr. Alessandra Solari

  57. Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany

    Article • Frontiers in Neurology, August 2019, Frontiers

    Dr. Alessandra Solari

  58. There is an urgent need for palliative care specialists in MS – Yes

    Article • Multiple Sclerosis Journal, July 2019, SAGE Publications

    Dr. Alessandra Solari

  59. Risk knowledge of people with relapsing-remitting multiple sclerosis – Results of an international survey

    Article • PLOS One, November 2018, PLOS

    Dr. Alessandra Solari

  60. Author Correction: Multiple sclerosis

    Article • Nature Reviews Disease Primers, November 2018, Springer Science + Business Media

    Professor Fredrik Piehl, Dr. Alessandra Solari

  61. Multiple sclerosis

    Article • Nature Reviews Disease Primers, November 2018, Springer Science + Business Media

    Professor Fredrik Piehl, Dr. Alessandra Solari

  62. Information provision for people with multiple sclerosis

    Article • Cochrane Database of Systematic Reviews, October 2018, Wiley

    Dr. Alessandra Solari

  63. Unmet needs of patients transitioning to secondary progressive multiple sclerosis: qualitative findings for a resource development

    Article • September 2018, Morressier

    Dr. Alessandra Solari

  64. THUR 172 Phase iv study of cladribine tablets and quality of life: clarify-ms

    Article • Journal of Neurology Neurosurgery & Psychiatry, September 2018, BMJ

    Dr. Alessandra Solari

  65. Patient and caregiver involvement in the formulation of guideline questions: findings from the European Academy of Neurology guideline on palliative care of people with severe multiple sclerosis

    Article • European Journal of Neurology, September 2018, Wiley

    Dr Emanuele D'amico , Professor Ivan G. Milanov, Dr. Alessandra Solari

  66. Palliative care team consultation and quality of death and dying in a university hospital: A secondary analysis of a prospective study

    Article • PLOS One, August 2018, PLOS

    Dr. Alessandra Solari

  67. Participant perspectives of a home-based palliative approach for people with severe multiple sclerosis: A qualitative study

    Article • PLOS One, July 2018, PLOS

    Dr. Alessandra Solari

  68. eMSQOL-29: Prospective validation of the abbreviated, electronic version of MSQOL-54

    Article • Multiple Sclerosis Journal, May 2018, SAGE Publications

    Dr. Alessandra Solari, Professor Barbara Loera

  69. Reliability and acceptability of the Multiple Sclerosis Quality of Life-29 questionnaire in an English-speaking cohort

    Article • Multiple Sclerosis Journal, May 2018, SAGE Publications

    Krishnan Nair, Dr. Alessandra Solari

  70. [Tecfidera® (delayed-release dimethylfumarate) in the treatment of relapsing-remitting multiple sclerosis]

    Article • Farmeconomia Health economics and therapeutic pathways, December 2017, Seed SRL

    Dr. Alessandra Solari

  71. What should a person with relapsing-remitting multiple sclerosis know? – Focus group and survey data of a risk knowledge questionnaire (RIKNO 2.0)

    Article • Multiple Sclerosis and Related Disorders, November 2017, Elsevier

    Dr. Alessandra Solari

  72. Equivalence of the electronic versus paper-based short version of the MSQOL-54 (MSQOL-29)

    Article • October 2017, Morressier

    Professor Barbara Loera, Dr. Alessandra Solari

  73. Managing the transition to secondary progressive multiple sclerosis: a scoping review

    Article • October 2017, Morressier

    Dr. Alessandra Solari

  74. Validity and reliability of multiple sclerosis quality of life-29 questionnaire in an english speaking cohort

    Article • Journal of the Neurological Sciences, October 2017, Elsevier

    Dr. Alessandra Solari

  75. Biomarkers predict outcome in Charcot-Marie-Tooth disease 1A

    Article • Journal of Neurology Neurosurgery & Psychiatry, August 2017, BMJ

    Dr. Alessandra Solari

  76. Trial of Minocycline in Clinically Isolated Syndrome of Multiple Sclerosis

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, August 2017, New England Journal of Medicine (NEJM/MMS)

    Dr. Alessandra Solari

  77. Managing the transition (ManTra): a resource for persons with secondary progressive multiple sclerosis and their health professionals: protocol for a mixed-methods study in Italy

    Article • BMJ Open, August 2017, BMJ

    Dr. Alessandra Solari

  78. Randomized controlled trial of a home-based palliative approach for people with severe multiple sclerosis

    Article • Multiple Sclerosis Journal, April 2017, SAGE Publications

    Dr. Alessandra Solari

  79. Effect of organizational features on patient satisfaction with care in Italian multiple sclerosis centres

    Article • European Journal of Neurology, February 2017, Wiley

    Dr. Alessandra Solari

  80. Erratum to: Home-based palliative approach for people with severe multiple sclerosis and their carers: study protocol for a randomized controlled trial

    Article • Trials, January 2017, Springer Science + Business Media

    Dr. Alessandra Solari

  81. Web-based medical and health information in multiple sclerosis: for patients and physicians

    Article • Neurodegenerative Disease Management, December 2016, Future Medicine

    Dr. Alessandra Solari

  82. Nerve conduction velocity in CMT 1A: what else can we tell?

    Article • European Journal of Neurology, July 2016, Wiley

    Dr. Alessandra Solari

  83. Low quality of life and psychological wellbeing contrast with moderate perceived burden in carers of people with severe multiple sclerosis

    Article • Journal of the Neurological Sciences, July 2016, Elsevier

    Prof Alessandra Lugaresi, Augusto Fusco, Dr. Alessandra Solari

  84. Individualized quality of life of severely affected multiple sclerosis patients: practicability and value in comparison with standard inventories

    Article • Quality of Life Research, April 2016, Springer Science + Business Media

    Augusto Fusco, Dr. Alessandra Solari

  85. Development of a Short Version of MSQOL-54 Using Factor Analysis and Item Response Theory

    Article • PLOS One, April 2016, PLOS

    Prof Alessandra Lugaresi, Dr. Alessandra Solari

  86. Erratum to: ‘Home-based palliative approach for people with severe multiple sclerosis and their carers: study protocol for a randomized controlled trial’

    Article • Trials, February 2016, Springer Science + Business Media

    Dr. Alessandra Solari

  87. Risk Knowledge in Relapsing Multiple Sclerosis (RIKNO 1.0) - Development of an Outcome Instrument for Educational Interventions

    Article • PLOS One, October 2015, PLOS

    Dr. Alessandra Solari

  88. Development of a shortened version of the MSQOL-54 using factor analysis and item response theory

    Article • Journal of the Neurological Sciences, October 2015, Elsevier

    Dr. Alessandra Solari

  89. Providing information for newly diagnosed people with multiple sclerosis

    Article • Journal of the Neurological Sciences, October 2015, Elsevier

    Dr. Alessandra Solari

  90. Role preferences in treatment decisions of MS patients in Italy

    Article • Journal of the Neurological Sciences, October 2015, Elsevier

    Dr. Alessandra Solari

  91. The ability to measure change of outcome measures in Charcot Marie Tooth neuropathy

    Article • European Journal of Neurology, July 2015, Wiley

    Dr. Alessandra Solari

  92. Patient Expression of Emotions and Neurologist Responses in First Multiple Sclerosis Consultations

    Article • PLOS One, June 2015, PLOS

    Prof Alessandra Lugaresi, Dr. Alessandra Solari

  93. Adherence to behavioural interventions in multiple sclerosis: Follow-up meeting report (AD@MS-2)

    Article • Multiple Sclerosis Journal - Experimental Translational and Clinical, May 2015, SAGE Publications

    Dr. Alessandra Solari

  94. Home-based palliative approach for people with severe multiple sclerosis and their carers: study protocol for a randomized controlled trial

    Article • Trials, April 2015, Springer Science + Business Media

    Prof Alessandra Lugaresi, Augusto Fusco, Dr. Alessandra Solari

  95. Azathioprine versus Beta Interferons for Relapsing-Remitting Multiple Sclerosis: A Multicentre Randomized Non-Inferiority Trial

    Article • PLOS One, November 2014, PLOS

    Dr. Alessandra Solari

  96. Adherence in multiple sclerosis (ADAMS): Classification, relevance, and research needs. A meeting report

    Article • Multiple Sclerosis Journal, November 2014, SAGE Publications

    Dr Jaume Sastre-Garriga, Dr. Alessandra Solari

  97. Selected items from the Charcot-Marie-Tooth (CMT) Neuropathy Score and secondary clinical outcome measures serve as sensitive clinical markers of disease severity in CMT1A patients

    Article • Neuromuscular Disorders, November 2014, Elsevier

    Dr. Alessandra Solari

  98. Unmet Needs of People with Severe Multiple Sclerosis and Their Carers: Qualitative Findings for a Home-Based Intervention

    Article • PLOS One, October 2014, PLOS

    Prof Alessandra Lugaresi, Dr. Alessandra Solari

  99. Pain and small fiber function in charcot–marie–tooth disease type 1A

    Article • Muscle & Nerve, May 2014, Wiley

    Dr. Alessandra Solari

  100. PMP22 messenger RNA levels in skin biopsies: testing the effectiveness of a Charcot-Marie-Tooth 1A biomarker

    Article • Brain, May 2014, Oxford University Press (OUP)

    Dr Davide Visigalli, Dr. Alessandra Solari

  101. Information provision for people with multiple sclerosis

    Article • Cochrane Database of Systematic Reviews, April 2014, Wiley

    Dr. Alessandra Solari

  102. Is overwork weakness relevant in Charcot–Marie–Tooth disease?

    Article • Journal of Neurology Neurosurgery & Psychiatry, March 2014, BMJ

    Dr. Alessandra Solari

  103. Effective communication at the point of multiple sclerosis diagnosis

    Article • Multiple Sclerosis Journal, February 2014, SAGE Publications

    Dr. Alessandra Solari

  104. Use of Rasch analysis to refine a patient-reported questionnaire on satisfaction with communication of the multiple sclerosis diagnosis

    Article • Multiple Sclerosis Journal, January 2014, SAGE Publications

    Dr. Alessandra Solari

  105. Implementation of the ‘Sapere Migliora’ information aid for newly diagnosed people with multiple sclerosis in routine clinical practice: a late-phase controlled trial

    Article • Multiple Sclerosis Journal, January 2014, SAGE Publications

    Dr. Alessandra Solari

  106. Patient autonomy in multiple sclerosis — Possible goals and assessment strategies

    Article • Journal of the Neurological Sciences, August 2013, Elsevier

    Dr. Alessandra Solari

  107. Authors’ response to Rahman and Fontes

    Article • PharmaNutrition, July 2013, Elsevier

    Dr. Alessandra Solari

  108. Role Preferences of People with Multiple Sclerosis: Image-Revised, Computerized Self-Administered Version of the Control Preference Scale

    Article • PLOS One, June 2013, PLOS

    Dr. Alessandra Solari

  109. Decision-Making in Multiple Sclerosis Consultations in Italy: Third Observer and Patient Assessments

    Article • PLOS One, April 2013, PLOS

    Prof Alessandra Lugaresi, Dr. Alessandra Solari

  110. Vitamin C and Charcot–Marie–Tooth 1A: Pharmacokinetic considerations

    Article • PharmaNutrition, January 2013, Elsevier

    Dr. Alessandra Solari

  111. Self‐assessed health status changes in a community cohort of people with multiple sclerosis: 11 years of follow‐up

    Article • European Journal of Neurology, December 2012, Wiley

    Dr. Alessandra Solari

  112. Quality of life reporting in multiple sclerosis clinical trials: enough quality?

    Article • Multiple Sclerosis Journal, December 2012, SAGE Publications

    Dr. Alessandra Solari

  113. Applying the theory of planned behaviour to multiple sclerosis patients’ decisions on disease modifying therapy – questionnaire concept and validation

    Article • BMC Medical Informatics and Decision Making, July 2012, Springer Science + Business Media

    Dr. Alessandra Solari

  114. Health‐related quality of life and depressive symptoms in significant others of people with multiple sclerosis: a community study

    Article • European Journal of Neurology, January 2012, Wiley

    Dr. Alessandra Solari

  115. Erythropoietin in Friedreich ataxia: No effect on frataxin in a randomized controlled trial

    Article • Movement Disorders, January 2012, Wiley

    Dr. Alessandra Solari

  116. Experience of an information aid for newly diagnosed multiple sclerosis patients: a qualitative study on the SIMS-Trial

    Article • Health Expectations, November 2011, Wiley

    Prof Alessandra Lugaresi, Dr. Alessandra Solari

  117. Natalizumab for relapsing remitting multiple sclerosis

    Article • Cochrane Database of Systematic Reviews, October 2011, Wiley

    Dr Eugenio Pucci, Dr. Alessandra Solari

  118. Anxiety and depression in multiple sclerosis patients around diagnosis

    Article • Journal of the Neurological Sciences, August 2011, Elsevier

    Prof Alessandra Lugaresi, Dr. Alessandra Solari

  119. Decisions on multiple sclerosis immunotherapy: New treatment complexities urge patient engagement

    Article • Journal of the Neurological Sciences, July 2011, Elsevier

    Dr. Alessandra Solari

  120. Iron-related MRI images in patients with pantothenate kinase-associated neurodegeneration (PKAN) treated with deferiprone: Results of a phase II pilot trial

    Article • Movement Disorders, May 2011, Wiley

    Dr. Alessandra Solari

  121. Treatment of first tonic-clonic seizure does not affect mortality: long-term follow-up of a randomised clinical trial

    Article • Journal of Neurology Neurosurgery & Psychiatry, April 2011, BMJ

    Dr. Alessandra Solari

  122. Ascorbic acid in Charcot–Marie–Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial

    Article • The Lancet Neurology, April 2011, Elsevier

    Dr. Alessandra Solari

  123. An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care

    Article • Multiple Sclerosis Journal, September 2010, SAGE Publications

    Dr. Alessandra Solari

  124. Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis

    Article • Multiple Sclerosis Journal, September 2010, SAGE Publications

    Dr. Alessandra Solari

  125. Methodological aspects of randomized controlled trials on cognitive interventions

    Article • Neurological Sciences, July 2010, Springer Science + Business Media

    Dr. Alessandra Solari

  126. Idebenone: a guide to its use in Alzheimerʼs disease, other age-related cognitive disorders and Friedreichʼs ataxia

    Article • Drugs & Therapy Perspectives, February 2010, Springer Science + Business Media

    Dr. Alessandra Solari

  127. The Multiple Sclerosis Knowledge Questionnaire: a self-administered instrument for recently diagnosed patients

    Article • Multiple Sclerosis Journal, December 2009, SAGE Publications

    Dr. Alessandra Solari

  128. Charcot–Marie–Tooth disease type 1A: is ascorbic acid effective?

    Article • The Lancet Neurology, December 2009, Elsevier

    Dr. Alessandra Solari

  129. Responsiveness of patient reported outcome measures in multiple sclerosis relapses: the REMS study

    Article • Journal of Neurology Neurosurgery & Psychiatry, May 2009, BMJ

    Dr. Alessandra Solari

  130. Accuracy of self-assessment of the minimal record of disability in patients with multiple sclerosis

    Article • Acta Neurologica Scandinavica, January 2009, Hindawi Publishing Corporation

    Dr. Alessandra Solari

  131. Natalizumab for relapsing remitting multiple sclerosis

    Article • January 2009, Wiley

    Dr Eugenio Pucci, Dr. Alessandra Solari

  132. ERRATUM

    Article • European Journal of Neurology, January 2009, Wiley

    Dr. Alessandra Solari

  133. Participatory decision making in multiple sclerosis

    Article • European Journal of Neurology, December 2008, Wiley

    Dr. Alessandra Solari

  134. Participation in medical decision-making: Attitudes of Italians with multiple sclerosis

    Article • Journal of the Neurological Sciences, December 2008, Elsevier

    Dr Eugenio Pucci, Dr. Alessandra Solari

  135. Treatment of recurrent glioblastoma: can local delivery of mitoxantrone improve survival?

    Article • Journal of Neuro-Oncology, February 2008, Springer Science + Business Media

    Dr. Alessandra Solari

  136. Reliability of clinical outcome measures in Charcot-Marie-Tooth disease

    Article • Neuromuscular Disorders, January 2008, Elsevier

    Dr. Alessandra Solari

  137. A shortened version of PASAT-3 is feasible

    Article • Multiple Sclerosis Journal, July 2007, SAGE Publications

    Dr. Alessandra Solari

  138. Biological abnormalities of peripheral A2A receptors in a large representation of polyglutamine disorders and Huntington's disease stages

    Article • Neurobiology of Disease, July 2007, Elsevier

    Dr. Alessandra Solari

  139. Cognitive Profiles and Visuoperceptual Abilities in Preterm and Term Spastic Diplegic Children With Periventricular Leukomalacia

    Article • Journal of Child Neurology, March 2007, SAGE Publications

    Dr. Alessandra Solari

  140. Communicating the diagnosis of multiple sclerosis - a qualitative study

    Article • Multiple Sclerosis Journal, February 2007, SAGE Publications

    Dr. Alessandra Solari

  141. Amantadine for fatigue in multiple sclerosis

    Article • Cochrane Database of Systematic Reviews, January 2007, Wiley

    Dr Eugenio Pucci, Dr. Alessandra Solari

  142. Randomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophy

    Article • Neurology, January 2007, Wolters Kluwer Health

    Dr. Alessandra Solari

  143. Treatment of the first tonic-clonic seizure does not affect long-term remission of epilepsy

    Article • Neurology, December 2006, Wolters Kluwer Health

    Dr. Alessandra Solari

  144. A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): The study protocol [EudraCT no.: 2006-000032-27]

    Article • Pharmacological Research, December 2006, Elsevier

    Dr. Alessandra Solari

  145. Improvement in Quality of Life and Activity Limitations in Migraine Patients after Prophylaxis. A Prospective Longitudinal Multicentre Study

    Article • Cephalalgia, June 2006, SAGE Publications

    Dr. Alessandra Solari

  146. A longitudinal survey of self-assessed health trends in a community cohort of people with multiple sclerosis and their significant others

    Article • Journal of the Neurological Sciences, April 2006, Elsevier

    Dr. Alessandra Solari

  147. Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis

    Article • Neurological Sciences, December 2005, Springer Science + Business Media

    Dr. Alessandra Solari

  148. Mortality in Patients with a First Unprovoked Seizure

    Article • Epilepsia, December 2005, Wiley

    Dr. Alessandra Solari

  149. Local drug delivery in recurrent malignant gliomas

    Article • Neurological Sciences, May 2005, Springer Science + Business Media

    Dr. Alessandra Solari

  150. Role of health-related quality of life measures in the routine care of people with multiple sclerosis

    Article • Health and Quality of Life Outcomes, March 2005, Springer Science + Business Media

    Dr. Alessandra Solari

  151. Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life

    Article • Blood, March 2005, American Society of Hematology

    Dr. Alessandra Solari

  152. The multiple sclerosis functional composite: different practice effects in the three test components

    Article • Journal of the Neurological Sciences, January 2005, Elsevier

    Dr. Alessandra Solari

  153. Disability and quality of life in different primary headaches: results from Italian studies

    Article • Neurological Sciences, October 2004, Springer Science + Business Media

    Dr. Alessandra Solari

  154. Disability in young patients suffering from primary headaches

    Article • Neurological Sciences, October 2004, Springer Science + Business Media

    Dr. Alessandra Solari

  155. Measuring responses to therapy in headache patients: new and traditional end-points

    Article • Neurological Sciences, October 2004, Springer Science + Business Media

    Dr. Alessandra Solari

  156. Corrigendum to “Computer-aided retraining of memory and attention in people with multiple sclerosis: a randomized, double-blind controlled trial” [J. Neurol. Sci. 222 (2004) 99–104]

    Article • Journal of the Neurological Sciences, September 2004, Elsevier

    Dr Eugenio Pucci, Dr. Alessandra Solari

  157. Computer-aided retraining of memory and attention in people with multiple sclerosis: a randomized, double-blind controlled trial

    Article • Journal of the Neurological Sciences, July 2004, Elsevier

    Dr Eugenio Pucci, Dr. Alessandra Solari

  158. General practitioners facing dementia: are they fully prepared?

    Article • Neurological Sciences, February 2004, Springer Science + Business Media

    Dr. Alessandra Solari

  159. Italian version of the Chicago multiscale depression inventory: translation, adaptation and testing in people with multiple sclerosis

    Article • Neurological Sciences, February 2004, Springer Science + Business Media

    Dr. Alessandra Solari

  160. Role of Gabapentin in Spinal Muscular Atrophy

    Article • Journal of Child Neurology, August 2003, SAGE Publications

    Prof Corrado Angelini, Dr. Alessandra Solari

  161. Idebenone treatment in Friedreich patients: One-year-long randomized placebo-controlled trial

    Article • Neurology, May 2003, Wolters Kluwer Health

    Dr. Alessandra Solari

  162. Quality of life and disability in primary chronic daily headaches

    Article • Neurological Sciences, May 2003, Springer Science + Business Media

    Dr. Alessandra Solari

  163. Health-Related Quality of Life in Patients with Cluster Headache During Active Periods

    Article • Cephalalgia, December 2002, SAGE Publications

    Dr. Alessandra Solari

  164. Reliability of hand‐held dynamometry in spinal muscular atrophy

    Article • Muscle & Nerve, June 2002, Wiley

    Dr. Alessandra Solari

  165. Comparison of two brief neuropsychological batteries in people with multiple sclerosis

    Article • Multiple Sclerosis Journal, April 2002, SAGE Publications

    Dr. Alessandra Solari

  166. Health status of people with multiple sclerosis: a community mail survey

    Article • Neurological Sciences, August 2001, Springer Science + Business Media

    Dr. Alessandra Solari

  167. Azathioprine and interferon beta-1b treatment in relapsing-remitting multiple sclerosis

    Article • Journal of Neurology Neurosurgery & Psychiatry, March 2001, BMJ

    Dr. Alessandra Solari

  168. Chronic inflammatory demyelinating polyradiculoneuropathy: long-term course and treatment of 60 patients

    Article • Neurological Sciences, April 2000, Springer Science + Business Media

    Dr. Alessandra Solari

  169. Validation of Italian multiple sclerosis quality of life 54 questionnaire

    Article • Journal of Neurology Neurosurgery & Psychiatry, August 1999, BMJ

    Dr. Alessandra Solari

  170. Physical rehabilitation has a positive effect on disability in multiple sclerosis patients

    Article • Neurology, January 1999, Wolters Kluwer Health

    Dr. Alessandra Solari

  171. Detection of hereditary neuropathy with liability to pressure palsies among patients with acute painless mononeuropathy or plexopathy

    Article • Muscle & Nerve, December 1998, Wiley

    Dr. Alessandra Solari

  172. Incidence and survival of childhood CNS tumours in the Region of Lombardy, Italy

    Article • Brain, August 1998, Oxford University Press (OUP)

    Dr. Alessandra Solari

  173. Affective disorders and multiple sclerosis: a controlled study on 65 Italian patients

    Article • Neurological Sciences, June 1998, Springer Science + Business Media

    Dr. Alessandra Solari

  174. Relation of cognitive impairment and depression to quality of life in multiple sclerosis patients

    Article • Neurological Sciences, January 1998, Springer Science + Business Media

    Dr. Alessandra Solari

  175. Treatment of first tonic-clonic seizure does not improve the prognosis of epilepsy

    Article • Neurology, October 1997, Wolters Kluwer Health

    Dr. Alessandra Solari

  176. Phenotypic heterogeneity in hereditary neuropathy with liability to pressure palsies associated with chromosome 17p11.2-12 deletion

    Article • Neurology, April 1996, Wolters Kluwer Health

    Dr. Alessandra Solari

  177. About Self-Assessment of Neurological Disability in Multiple Sclerosis

    Article • International Journal of Epidemiology, January 1995, Oxford University Press (OUP)

    Dr. Alessandra Solari

  178. Agreement in the Clinical Diagnosis of Dementia: Evaluation of a Case Series with Mild Cognitive Impairment

    Article • Neuroepidemiology, January 1994, Karger Publishers

    Dr. Alessandra Solari

  179. A multicenter Italian randomised study on early treatment of Parkinson disease: comparison of 1-dopa, 1-deprenyl and dopaminoagonists. Study design and short term results

    Article • Neurological Sciences, December 1992, Springer Science + Business Media

    Dr. Alessandra Solari

  180. Interobserver Agreement in the Diagnosis of Multiple Sclerosis

    Article • Archives of Neurology, March 1989, American Medical Association (AMA)

    Dr. Alessandra Solari

  181. Classic Migraine – Clinical Findings in 164 Patients

    Article • European Neurology, January 1985, Karger Publishers

    Dr. Alessandra Solari